Ilex Capital Partners UK LLP Purchases Shares of 474,934 GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Ilex Capital Partners UK LLP bought a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) during the third quarter, according to its most recent 13F filing with the SEC. The fund bought 474,934 shares of the company's stock, valued at approximately $44,573,000. GE HealthCare Technologies comprises about 3.0% of Ilex Capital Partners UK LLP's holdings, making the stock its 15th largest position. Ilex Capital Partners UK LLP owned about 0.10% of GE HealthCare Technologies at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in GEHC. D1 Capital Partners L.P. purchased a new position in GE HealthCare Technologies during the third quarter worth $268,159,000. Van ECK Associates Corp purchased a new position in shares of GE HealthCare Technologies during the 3rd quarter worth about $208,513,000. Massachusetts Financial Services Co. MA purchased a new position in shares of GE HealthCare Technologies during the 3rd quarter worth about $93,713,000. Marshall Wace LLP bought a new position in GE HealthCare Technologies during the 2nd quarter valued at about $63,639,000. Finally, International Assets Investment Management LLC lifted its stake in GE HealthCare Technologies by 10,227.3% in the third quarter. International Assets Investment Management LLC now owns 621,913 shares of the company's stock worth $58,367,000 after purchasing an additional 615,891 shares during the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at GE HealthCare Technologies

In related news, CEO Roland Rott sold 3,577 shares of GE HealthCare Technologies stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total transaction of $309,338.96. Following the completion of the sale, the chief executive officer now owns 24,298 shares of the company's stock, valued at $2,101,291.04. The trade was a 12.83 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 0.27% of the company's stock.

GE HealthCare Technologies Stock Down 0.6 %

GE HealthCare Technologies stock traded down $0.51 during trading hours on Tuesday, reaching $82.57. The stock had a trading volume of 2,026,619 shares, compared to its average volume of 3,063,322. The company has a market cap of $37.72 billion, a price-to-earnings ratio of 22.68, a PEG ratio of 2.97 and a beta of 1.07. The business's 50 day moving average price is $87.62 and its 200-day moving average price is $83.67. GE HealthCare Technologies Inc. has a 52 week low of $67.00 and a 52 week high of $94.55. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share for the quarter, topping the consensus estimate of $1.06 by $0.08. The firm had revenue of $4.86 billion for the quarter, compared to the consensus estimate of $4.87 billion. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The firm's revenue for the quarter was up .9% on a year-over-year basis. During the same period in the previous year, the business earned $0.99 EPS. Sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 EPS for the current year.

GE HealthCare Technologies Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th will be issued a $0.035 dividend. The ex-dividend date of this dividend is Tuesday, January 14th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.17%. This is a boost from GE HealthCare Technologies's previous quarterly dividend of $0.03. GE HealthCare Technologies's dividend payout ratio (DPR) is currently 3.30%.

Wall Street Analysts Forecast Growth

GEHC has been the topic of a number of analyst reports. JPMorgan Chase & Co. initiated coverage on GE HealthCare Technologies in a research note on Monday, September 9th. They set a "neutral" rating and a $90.00 target price on the stock. UBS Group cut shares of GE HealthCare Technologies from a "neutral" rating to a "sell" rating and lowered their price objective for the company from $84.00 to $74.00 in a research report on Thursday, September 26th. BTIG Research raised shares of GE HealthCare Technologies from a "neutral" rating to a "buy" rating and set a $100.00 target price on the stock in a research report on Wednesday, September 18th. Wells Fargo & Company boosted their price target on GE HealthCare Technologies from $95.00 to $96.00 and gave the company an "overweight" rating in a report on Thursday, October 31st. Finally, Evercore ISI raised their price objective on GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an "outperform" rating in a report on Tuesday, October 1st. One research analyst has rated the stock with a sell rating, four have given a hold rating, eight have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, GE HealthCare Technologies presently has an average rating of "Moderate Buy" and an average price target of $95.46.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.